Adverse Drug Reactions in Norway: A Systematic Review
Prescription medicines aim to relieve patients’ suffering but they can be associated with adverse side effects or adverse drug reactions (ADRs). ADRs are an important cause of hospital admissions and a financial burden on healthcare systems across the globe. There is little integrative and...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | Pharmacy |
Subjects: | |
Online Access: | https://www.mdpi.com/2226-4787/7/3/102 |
_version_ | 1811184962946203648 |
---|---|
author | Mojtaba Vaismoradi Patricia A. Logan Sue Jordan Hege Sletvold |
author_facet | Mojtaba Vaismoradi Patricia A. Logan Sue Jordan Hege Sletvold |
author_sort | Mojtaba Vaismoradi |
collection | DOAJ |
description | Prescription medicines aim to relieve patients’ suffering but they can be associated with adverse side effects or adverse drug reactions (ADRs). ADRs are an important cause of hospital admissions and a financial burden on healthcare systems across the globe. There is little integrative and collective knowledge on ADR reporting and monitoring in the Norwegian healthcare system. Accordingly, this systematic review aims to investigate the current trends in ADR reporting, monitoring, and handling in the Norwegian healthcare system and describe related interventions. Appropriate keywords, with regard to ADRs in both English and Norwegian languages, were used to retrieve articles published from 2010 to 2019. Six articles met the inclusion criteria. The findings offer a comprehensive picture of ADR reporting and monitoring in the Norwegian healthcare system. Psychotropic medicines were most commonly implicated by patients, while professionals most commonly reported ADRs associated with anticoagulants. The current ADR systems were compiled with the involvement of both patients and healthcare providers to record all types of drugs and ADRs of various severities, and aimed at improving ADR tracking. However, there is a need to improve current initiatives in terms of feedback and quality, and more studies are needed to explore how ADR profiles, and the associated vigilance, can improve the safety of medicines management in Norway. |
first_indexed | 2024-04-11T13:21:22Z |
format | Article |
id | doaj.art-5306a80bf986425c992814133d628461 |
institution | Directory Open Access Journal |
issn | 2226-4787 |
language | English |
last_indexed | 2024-04-11T13:21:22Z |
publishDate | 2019-07-01 |
publisher | MDPI AG |
record_format | Article |
series | Pharmacy |
spelling | doaj.art-5306a80bf986425c992814133d6284612022-12-22T04:22:11ZengMDPI AGPharmacy2226-47872019-07-017310210.3390/pharmacy7030102pharmacy7030102Adverse Drug Reactions in Norway: A Systematic ReviewMojtaba Vaismoradi0Patricia A. Logan1Sue Jordan2Hege Sletvold3Faculty of Nursing and Health Sciences, Nord University, 8049 Bodø, NorwayFaculty of Science, Charles Sturt University, Bathurst 2795, NSW, AustraliaCollege of Human and Health Sciences, Swansea University, Swansea SA2 8PP, UKFaculty of Nursing and Health Sciences, Nord University, 8049 Bodø, NorwayPrescription medicines aim to relieve patients’ suffering but they can be associated with adverse side effects or adverse drug reactions (ADRs). ADRs are an important cause of hospital admissions and a financial burden on healthcare systems across the globe. There is little integrative and collective knowledge on ADR reporting and monitoring in the Norwegian healthcare system. Accordingly, this systematic review aims to investigate the current trends in ADR reporting, monitoring, and handling in the Norwegian healthcare system and describe related interventions. Appropriate keywords, with regard to ADRs in both English and Norwegian languages, were used to retrieve articles published from 2010 to 2019. Six articles met the inclusion criteria. The findings offer a comprehensive picture of ADR reporting and monitoring in the Norwegian healthcare system. Psychotropic medicines were most commonly implicated by patients, while professionals most commonly reported ADRs associated with anticoagulants. The current ADR systems were compiled with the involvement of both patients and healthcare providers to record all types of drugs and ADRs of various severities, and aimed at improving ADR tracking. However, there is a need to improve current initiatives in terms of feedback and quality, and more studies are needed to explore how ADR profiles, and the associated vigilance, can improve the safety of medicines management in Norway.https://www.mdpi.com/2226-4787/7/3/102adverse drug reactionspatient safetynursingmedicines managementhealthcare providerADR |
spellingShingle | Mojtaba Vaismoradi Patricia A. Logan Sue Jordan Hege Sletvold Adverse Drug Reactions in Norway: A Systematic Review Pharmacy adverse drug reactions patient safety nursing medicines management healthcare provider ADR |
title | Adverse Drug Reactions in Norway: A Systematic Review |
title_full | Adverse Drug Reactions in Norway: A Systematic Review |
title_fullStr | Adverse Drug Reactions in Norway: A Systematic Review |
title_full_unstemmed | Adverse Drug Reactions in Norway: A Systematic Review |
title_short | Adverse Drug Reactions in Norway: A Systematic Review |
title_sort | adverse drug reactions in norway a systematic review |
topic | adverse drug reactions patient safety nursing medicines management healthcare provider ADR |
url | https://www.mdpi.com/2226-4787/7/3/102 |
work_keys_str_mv | AT mojtabavaismoradi adversedrugreactionsinnorwayasystematicreview AT patriciaalogan adversedrugreactionsinnorwayasystematicreview AT suejordan adversedrugreactionsinnorwayasystematicreview AT hegesletvold adversedrugreactionsinnorwayasystematicreview |